Does Medicare Cover Cochlear Implants? The Criteria and What You Pay

Yes. Medicare may cover cochlear implantation when a person meets every criterion in its national coverage determination, in effect for services on or after September 26, 2022. Part A or Part B pays, according to whether the surgery is inpatient or outpatient. Under Part B you pay 20% of the Medicare-approved amount after the 2026 deductible of $283.

Figure 1

Coverage and payment rules, as published

Each rule is shortened from its source, linked below. It applies only as far as its source reaches.

Coverage and payment rules, as published
Covered indication “Effective for services performed on or after September 26, 2022, cochlear implantation may be covered for treatment of bilateral pre- or post-linguistic, sensorineural, moderate-to-profound hearing loss in individuals who demonstrate limited benefit from amplification.” September 26, 2022
Limited benefit “Limited benefit from amplification is defined by test scores of less than or equal to 60% correct in the best-aided listening condition on recorded tests of open-set sentence recognition.” September 26, 2022
Hearing “Diagnosis of bilateral moderate-to-profound sensorineural hearing impairment with limited benefit from appropriate hearing (or vibrotactile) aids” September 26, 2022
Rehabilitation “Cognitive ability to use auditory clues and a willingness to undergo an extended program of rehabilitation” September 26, 2022
Ear and nerve “Freedom from middle ear infection, an accessible cochlear lumen that is structurally suited to implantation, and freedom from lesions in the auditory nerve and acoustic areas of the central nervous system” September 26, 2022
Surgery “No contraindications to surgery” September 26, 2022
Device “The device must be used in accordance with Food and Drug Administration (FDA)-approved labeling.” September 26, 2022
Criteria not all met “Medicare beneficiaries not meeting all of the coverage criteria for cochlear implantation listed in Section B are deemed not eligible for Medicare coverage except as described in Section D below.” September 26, 2022
Clinical trial route “CMS may provide coverage of cochlear implants for beneficiaries not meeting the coverage criteria listed in Section B when performed in the context of FDA-approved category B investigational device exemption clinical trials as defined at 42 CFR 405.201 or as a routine cost in clinical trials under section 310.1 of the National Coverage Determinations Manual titled Routine Costs in Clinical Trials.” September 26, 2022
Source:

Figure 2

Hospital outpatient payment rates (OPPS)

National rates, not a hospital's price. The indicator is the OPPS status indicator. Copayment fields are copied as written; an empty cell means the file gives no value.

Hospital outpatient payment rates (OPPS)
69930 J1 5166 33686.28 6942.79 6737.26 1736.00
Source:
How to read these numbers (2)
  • Reference data; source scope and effective dates travel with each fact.
  • No retail price, eligibility or disability rating is calculated.

What are Medicare's criteria for a cochlear implant?

Medicare's national coverage determination for cochlear implantation sets the criteria, effective for services performed on or after September 26, 2022. The covered indication is bilateral pre- or post-linguistic, sensorineural, moderate-to-profound hearing loss in individuals who demonstrate limited benefit from amplification.

The determination defines limited benefit with one test: scores of 60% correct or less on recorded tests of open-set sentence recognition, taken “in the best-aided listening condition”.

It then lists the criteria a beneficiary must meet. In the source's wording:

  • Hearing: bilateral moderate-to-profound sensorineural hearing impairment with limited benefit from appropriate hearing (or vibrotactile) aids.
  • Rehabilitation: cognitive ability to use auditory clues and a willingness to undergo an extended program of rehabilitation.
  • Ear and nerve: freedom from middle ear infection, an accessible cochlear lumen that is structurally suited to implantation, and freedom from lesions in the auditory nerve and acoustic areas of the central nervous system.
  • Surgery: no contraindications to surgery.
  • Device: the device must be used in accordance with Food and Drug Administration (FDA)-approved labeling.

This page reports the criteria as CMS publishes them. It makes no assessment of any one person's case.

What if a person meets only some of the criteria?

The determination answers in two steps. Section C says Medicare beneficiaries not meeting all of the coverage criteria listed in Section B are deemed not eligible for Medicare coverage, except as described in Section D.

Section D opens a narrow route through research. CMS may provide coverage for beneficiaries outside the criteria when the implant is performed in an FDA-approved category B investigational device exemption clinical trial, as defined at 42 CFR 405.201. Coverage may also come as a routine cost in clinical trials under section 310.1 of the National Coverage Determinations Manual. CMS records that the determination was last reviewed in September 2022.

Which part of Medicare pays, and what do you owe?

Part A or Part B pays, depending on the setting. Medicare.gov says either part covers a surgically implanted prosthetic device, depending on if the surgery takes place in an inpatient or outpatient setting.

For Part B, the 2026 amounts on Medicare.gov are:

  • Deductible: $283 before Original Medicare starts to pay, owed once each year.
  • Coinsurance: 20% of the Medicare-approved amount for a prosthetic device, once the deductible is met.

Medicare.gov applies coinsurance to each Medicare-covered service or item. Medicare also pays for a prosthetic device only when it comes from a supplier that participates in Medicare.

What copayment does the outpatient hospital file list?

For an outpatient implant in a hospital, the CMS OPPS Addendum B for October 2026 prints three copayment fields on the row for surgery code 69930:

  • National unadjusted copayment: $6,942.79.
  • Minimum unadjusted copayment: $6,737.26.
  • Adjusted beneficiary copayment: $1,736.00.

The Note column of the same row explains the adjusted figure: “Copayments capped at inpatient deductible of $1,736.00.”

The same row carries status indicator J1, APC 5166 and a national payment rate of $33,686.28. All of these are national CMS figures from a fee schedule. We report each field as CMS prints it. We derive no personal copayment from them, and none from the 20% rate either.

Where do the surgery center and surgeon amounts fit?

An ambulatory surgical center is paid from a separate CMS file. Its October 2026 row for code 69930 shows payment indicator J8, the device-intensive flag and a national payment rate of $29,768.66. That file publishes no copayment for the row, so those cells stay empty.

The surgeon is paid under the Physician Fee Schedule. For 69930, the national facility amount is $1,059.81: the file's 31.73 total relative value units multiplied by its conversion factor of 33.4009. It is the national amount before geographic adjustment, and it sits apart from the facility payment.

The hospital rate and the surgery center rate describe two different settings. They are alternatives, so neither is added to the other or to the surgeon's amount. A full breakdown by setting, programming code and Medicaid year is on cochlear implant cost.

Frequently asked questions

How much does Medicare pay for cochlear implants?

It depends on the setting and on who bills. In the October 2026 files, hospital outpatient departments receive a national rate of $33,686.28 for code 69930, and ambulatory surgical centers $29,768.66. The surgeon's national facility amount under the Physician Fee Schedule is $1,059.81. Your own share follows the Part B rules and the copayment fields described above; the hospital row notes: “Copayments capped at inpatient deductible of $1,736.00.”

How bad does your hearing have to be to qualify for a cochlear implant?

For Medicare, the criteria in effect since September 26, 2022 name bilateral moderate-to-profound sensorineural hearing loss with limited benefit from amplification. Limited benefit means test scores of 60% correct or less on recorded open-set sentence recognition tests, “in the best-aided listening condition”. The rehabilitation, ear, surgery and device criteria listed above apply as well.

Are cochlear ear implants covered by insurance?

Original Medicare can cover them when every criterion in its national coverage determination is met, with Part A or Part B paying according to whether the surgery is inpatient or outpatient. Under Part B, the deductible for 2026 is $283. What Medicaid paid nationally for implant device codes, by year, is shown on cochlear implant cost.

Sources

Criteria are quoted from the CMS national coverage determination for cochlear implantation, and cost-sharing rules from Medicare.gov, read in October 2026. Facility amounts come from the CMS OPPS Addendum B and ASC rate files for October 2026. The surgeon's amount is our product of the 2026 Physician Fee Schedule relative value units and conversion factor, at national values. No eligibility and no personal copayment are calculated.

  1. https://www.medicare.gov/coverage/prosthetic-devices
  2. https://www.medicare.gov/basics/costs/medicare-costs
  3. https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=245&ncdver=3
  4. https://www.cms.gov/files/zip/October-2026-OPPS-Addendum-B.zip
  5. https://www.cms.gov/files/zip/october-2026-asc-approved-hcpcs-code-payment-rates.zip
  6. https://www.cms.gov/files/zip/rvu26d-updated-08-26-2026.zip

Cost and coverage research, not medical advice. This page quotes Medicare's criteria and does not decide whether you qualify; confirm coverage with Medicare and your implant team.